Prior to Civitas he served as CEO of BIND Biosciences (acquired by Pfizer), CEO of Acceleron Pharma (NASDAQ: XLRN) and SVP of Operations at Millennium Pharmaceuticals (acquired by Takeda).
During his more than 30 years of executive leadership experience he also served in functional roles including sales, marketing, business development, manufacturing, supply chain management and R&D.
He currently serves as Chairman of the Board for Synchronicity Pharma and XyloCor Therapeutics and serves on the board of directors for Synspira. He also serves on the non-profit board of directors for the Michael J. Fox Foundation for Parkinson’s Research and The Possible Project. He is the former Chairman of the MassBio board.